摘要
目的观察孟鲁司特钠治疗小儿咳嗽变异性哮喘的临床疗效;方法本研究所选对象为我院2015年6月至2017年1月收治的咳嗽变异性哮喘患儿48例,将全部48例患儿经数字随机方法分成两组,对照组(24例)选择布地奈德治疗,实验组(24例)则在布地奈德治疗的同时采用孟鲁司特钠治疗,观察分析临床疗效;结果实验组的临床治疗总有效率(91.7%)显著高于对照组的(70.8%)、两者比较差异有统计学意义(P<0.05);对照组和实验组的不良反应发生率比较差异无统计学意义(P>0.05)。结论在对咳嗽变异性哮喘患儿进行治疗时,采用孟鲁司特钠治疗安全可靠,值得推广。
Objective To observe the clinical effect of montelukast in treating cough variant asthma; Methods The research object is selected in our hospital from June 2015 to January 2017 were 48 cases of children with cough variant asthma, according to the principle of all patients randomly divided into control group and experimental group, each group had 24 cases. The control group were selected in the experimental group, budesonide treatment, while budesonide treatment with montelukast treatment, observation of clinical curative effect analysis; Results The control group of children with clinical and experimental group with the total effective rate are 70.8 %(17/24), 91.7 %(22/24), in the clinical treatment of total efficiency, the experimental group was significantly higher than the control group(P<0.05); in the incidence of adverse reactions, no significant differences between the two groups(P>0.05). ConclusionIn the treatment of children with cough variant asthma, montelukast sodium treatment of clinical efficacy is significant, and has high safety, worthy of clinical promotion and application.
出处
《智慧健康》
2017年第13期117-118,共2页
Smart Healthcare
关键词
小儿
咳嗽变异性哮喘
孟鲁司特钠
临床疗效
Children
Cough Variant Asthma
Montelukast Sodium
Clinical Efficacy
